↓ Skip to main content

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis - Volume 26, Number 3—March 2020 - Emerging Infectious Diseases journal - CDC

Overview of attention for article published in Emerging Infectious Diseases, March 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
38 Mendeley
Title
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis - Volume 26, Number 3—March 2020 - Emerging Infectious Diseases journal - CDC
Published in
Emerging Infectious Diseases, March 2020
DOI 10.3201/eid2603.190997
Pubmed ID
Authors

Jonathon R. Campbell, Dennis Falzon, Fuad Mirzayev, Ernesto Jaramillo, Giovanni Battista Migliori, Carole D. Mitnick, Norbert Ndjeka, Dick Menzies

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 18%
Student > Master 5 13%
Student > Bachelor 3 8%
Other 2 5%
Student > Postgraduate 2 5%
Other 2 5%
Unknown 17 45%
Readers by discipline Count As %
Medicine and Dentistry 8 21%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Nursing and Health Professions 4 11%
Computer Science 2 5%
Agricultural and Biological Sciences 1 3%
Other 2 5%
Unknown 17 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2022.
All research outputs
#6,303,376
of 25,387,668 outputs
Outputs from Emerging Infectious Diseases
#4,790
of 9,718 outputs
Outputs of similar age
#120,410
of 404,770 outputs
Outputs of similar age from Emerging Infectious Diseases
#73
of 167 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,718 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,770 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.